Document Title
Date of Publication
Previous Versions and Notes
Infective endocarditis - EUCAST guidance on the reporting of antimicrobial susceptibility testing results
July 2025
December 2024
Daptomycin in endocarditis and bloodstream infections caused by enterococci
April 2025
April 2020
Also available in CMI as a EUCAST position paper (2020)
Guidance on the use of cephalosporins in Staphylococcus aureus
February 2025
2025, 2023
Guidance on antimicrobial agents for Stenotrophomonas maltophilia
15 November 2024
February 2012
See also the narrative review in CMI (2025)
When there are no breakpoints
September 2024
29 February 2024
30 June 2023
December 2021 - 30 June 2023
July 2016 - December 2021
Guidance on the use of fosfomycin intravenously
28 May 2024
December 2023
ATU - the Area of Technical Uncertainty - Guidance to laboratories on how to deal with the ATU in antimicrobial susceptibility testing (originally published 2018; updated 2019, 2020, 2022, and 8 February 2024).
8 February 2024
Originally published 2018; updated 2019, 2020, 2022, and 8 February 2024
Graphs to illustrate ATUs (Updated 5 February 2024)
Cefiderocol MIC broth microdilution guide
1 January 2024
See also the Warning on cefiderocol susceptibility testing
Guidance on the Implementation of Revised Aminopenicillin Breakpoints for Enterobacterales
15 September 2023
Phenotypic screening tests to detect and exclude resistance of clinical relevance
22 August 2022
13 June 2022
2 February 2022
1 December 2021
Guidance on tigecycline dosing
21 July 2022
23 December 2018
Breakpoints for topical use of antimicrobial agents
12 April 2022
21 November 2019
22 December 2016
Implementation and use of the 2022 revised colistin breakpoints
January 2022
November 2021
EUCAST system for antimicrobial name abbreviations
13 July 2018
Setting breakpoints for agent-inhibitor combinations
14 December 2021
2 October 2017
Breakpoints in brackets in breakpoint tables
2 December 2021
Oral cephalosporins and Enterobacterales breakpoints
14 July 2020
16 February 2012
Legionella pneumophila susceptibility testing
30 May 2021
11 December 2017
Implementation and use of the 2020 revised aminoglycoside breakpoints
21 January 2020
Guidance for industry on the working order between pharmaceutical industry, EMA and EUCAST
5 May 2019
Cefotaxime and ceftazidime disks with and without clavulanic acid for ESBL confirmation
12 February 2019
The 2019 modifications of susceptibility categories S, I and R categories
22 October 2018
This presentation also informs laboratories on how to implement the Area of Technical Uncertainty.
Recommendations for colistin (polymyxin E) MIC testing
22 March 2016
Burkholderia cepacia complex
20 July 2013
Direct susceptibility testing
See also EUCAST Rapid AST directly from positive blood culture bottles
For previous versions of documents, see the document archive.
Looking for more information? Get in touch with an EUCAST representative today!
Contact form
We’ve prepared a short video to help you get familiar with the new layout and features.
